Zhili Liu

Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.

Shanglin Zhou, Bo Gao, Xuechu Zhen, 2011, Journal of medicinal chemistry.

Synthesis and pharmacological investigation of novel 2-aminothiazole-privileged aporphines.

Xuechu Zhen, Xuechu Zhen, Zhili Liu, 2008, Bioorganic & medicinal chemistry.

Synthesis of dihydrofuroaporphine derivatives: identification of a potent and selective serotonin 5-HT 1A receptor agonist.

Xuechu Zhen, Hai Zhang, Na Ye, 2010, Journal of medicinal chemistry.

(6aR)-11-Amino-N-propyl-noraporphine, a new dopamine D2 and serotonin 5-HT1A dual agonist, elicits potent antiparkinsonian action and attenuates levodopa-induced dyskinesia in a 6-OHDA-lesioned rat model of Parkinson's disease

Xuechu Zhen, Lin Guo, L. Zheng, 2014, Pharmacology Biochemistry and Behavior.

Design of multivalent ligand targeting G-protein-coupled receptors.

Zhili Liu, A. Zhang, Jing Zhang, 2009, Current pharmaceutical design.

N-Propylnoraporphin-11-O-yl carboxylic esters as potent dopamine D(2) and serotonin 5-HT(1A) receptor dual ligands.

Xuechu Zhen, Zhili Liu, A. Zhang, 2008, Bioorganic & medicinal chemistry.

Receptor dimerization--rationale for the design of bivalent ligands.

Zhili Liu, Ao Zhang, Y. Kan, 2007, Current topics in medicinal chemistry.